Fi Dog Supplements Recalled Over Salmonella Risk Amid Pet Food Safety Scrutiny

Fi Dog Supplements Recalled Over Salmonella Risk Amid Pet Food Safety Scrutiny

New York-based Fi has issued a voluntary recall for two of its dog supplement products due to potential Salmonella contamination, following an alert from the U.S. Food and Drug Administration (FDA). The recall, announced on September 3, 2026, affects specific lots of Fi Calming Supplement for Dogs and Fi 8-in-1 Formula Supplement for Dogs, both sold in 180-gram containers. The products were distributed directly to consumers and through major online retailers Amazon and Chewy.com.

The FDA’s recall notice states that the potential contamination stems from an ingredient supplied to Fi’s manufacturer, which has since suspended production while investigating the source. Fi said it is notifying affected customers "out of an abundance of caution," according to the agency’s notice. The recall is the latest in a series of pet food and supplement safety actions that have heightened scrutiny on the industry.

Affected Lots and What Consumers Should Do

Consumers who purchased the recalled products should stop using them immediately, tightly seal the container, and dispose of it in the trash. The affected products are identified by lot number and UPC code:

• Fi Calming Supplement for Dogs – 180g, Lot #26118, UPC 8 50064 80011 1
• Fi 8-in-1 Formula Supplement for Dogs – 180g, Lot #26159, UPC 8 50055 11168 4

Fi is directly notifying customers who purchased these lots. For questions, consumers can contact the company at 1-888-434-3647, seven days a week from 10 a.m. to 8 p.m. Eastern time, or via email to the company’s support team.

Why Salmonella in Pet Products Matters

Salmonella is a bacterium that can cause serious illness in both animals and humans. In dogs, symptoms of infection include lethargy, diarrhea or bloody diarrhea, fever, and vomiting. Some pets may only show mild signs, such as decreased appetite, fever, and abdominal pain. Critically, infected but otherwise healthy pets can become carriers and spread the bacteria to other animals or humans, according to the FDA.

For humans, handling contaminated products or coming into contact with an infected animal’s waste can lead to salmonellosis. Symptoms typically develop within 8 to 72 hours of exposure and include diarrhea, fever, and abdominal cramps. Most healthy individuals recover within a week without treatment, but severe cases can lead to dehydration, bloodstream infections, and other complications, especially in infants, the elderly, pregnant women, and those with weakened immune systems. The FDA advises anyone who develops these symptoms after handling the recalled products to seek medical attention.

A Pattern of Recalls in Pet Food and Supplements

The Fi recall is not an isolated event. In late August 2026, Northwest Naturals voluntarily recalled two raw pet food products after FDA testing detected Salmonella and Listeria monocytogenes. The recall involved frozen chicken recipes for cats and dogs, distributed nationwide to retail stores. No illnesses were reported in that case, but the company took precautionary action.

These incidents underscore a broader trend: pet food and supplement recalls have been increasing in frequency, driven by both regulatory oversight and heightened consumer awareness. In recent months, other recalls have included dog and horse medications due to glass fiber found in vials, and frozen dog food linked to multiple pet illnesses. The FDA has been more proactive in testing and issuing public notices, which has led to a growing list of products being pulled from shelves and online marketplaces.

The Stakes for Pet Owners and the Industry

For pet owners, these recalls are a stark reminder that even products marketed as health supplements can pose risks. The convenience of buying pet products online through platforms like Amazon and Chewy amplifies the challenge of tracking recalls, as consumers may not check lot numbers or notices regularly. Health experts recommend that pet owners register their products (if possible), monitor recall announcements, and observe their pets for any unusual symptoms after introducing new food or supplements.

The economic impact on companies can be significant. A recall often leads to direct financial losses, damage to brand reputation, and potential legal liability. In Fi’s case, the company is cooperating with the FDA and has halted production, which could disrupt supply and affect revenue. The manufacturer’s suspension of production suggests that the root cause is still under investigation, leaving uncertainty about when products will return to the market.

Regulatory Oversight and Consumer Trust

The FDA’s role in identifying and publicizing these recalls is crucial, but some consumer advocates argue that the agency’s resources are stretched thin. The pet food industry is booming, with supplements and premium diets becoming a multi-billion-dollar market. However, the regulatory framework for pet supplements is less stringent than that for human pharmaceuticals, relying largely on post-market surveillance and voluntary recalls.

This incident may prompt calls for stronger manufacturing standards and more rigorous ingredient testing. For now, the FDA advises that "consumers who have purchased any of the above product lots should discontinue use of the product, make sure the container is tightly sealed, and dispose of it in the trash." The agency also encourages reporting of any pet illnesses to the FDA’s Safety Reporting Portal.

Broader Implications for Pet Health and Food Safety

This recall highlights the interconnectedness of human and animal health, a concept known as One Health. Pathogens like Salmonella can easily cross species barriers, and the close relationship between pets and their owners increases the risk of zoonotic transmission. As more households treat pets as family members, the demand for high-quality, safe products grows.

In response to recent recalls, some pet food companies are voluntarily implementing more rigorous testing protocols, while others are turning to third-party certifications to reassure consumers. Yet, the recent incidents suggest that even well-intentioned companies can face supply chain vulnerabilities.

What This Changes for the Industry and Consumers

For the pet supplement market, the Fi recall may serve as a wake-up call. It could lead to tighter quality control measures, more transparent sourcing, and improved traceability. Consumers, meanwhile, are becoming more vigilant about checking lot numbers and expiry dates, and more likely to seek out brands with a strong safety track record.

The FDA’s notice serves as a reminder that “Salmonella poses a risk not only to dogs that consume the tainted supplements but also to the people who handle the products or clean up after affected animals.” This is especially important for households with young children, elderly family members, or immunocompromised individuals.

As the investigation continues, Fi has stated it will provide updates through its website and customer support channels. In the meantime, pet owners who purchased the recalled lots should act promptly to protect both their animals and themselves. The situation also underscores the importance of staying informed about product recalls, particularly for items sold online, where notices may not be as prominent.

For those seeking more on similar recall issues, recent coverage of allergen-related recalls in human food shows how widespread safety concerns can be across the industry.

Conclusion

The voluntary recall of Fi dog supplements over Salmonella concerns is a significant development for pet owners and the broader pet product industry. With both pet and human health at risk, the FDA’s swift action and Fi’s cooperation highlight the importance of transparency and vigilance in the supply chain. As the manufacturer works to identify the source of contamination, the incident serves as a cautionary tale for all producers of animal consumables.

For now, consumers should check their supplies, follow disposal instructions, and monitor their pets for any signs of illness. The FDA and Fi have made consumer safety the top priority, but the long-term impact on brand trust and regulatory practices remains to be seen. With the pet industry continuing to expand, ensuring the safety of these products will remain a critical challenge.